Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort
Tiago de Castro, Sabrina Welland, Leonie Jochheim, Cathrine Leyh, Kateryna Shmanko, Fabian Finkelmeier, Petia Jeliazkova, Andre Jefremow, Maria A Gonzalez-Carmona, Arne Kandulski, Daniel Roessler, Najib Ben Khaled, Stefan Enssle, Marino Venerito, Thorben W Fründt, Michael Schultheiß, Angela Djanani, · 2024
Read Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort by Tiago de Castro, Sabrina Welland, Leonie Jochheim, Cathrine Leyh, Kateryna Shmanko, Fabian Finkelmeier, Petia Jeliazkova, Andre Jefremow, Maria A Gonzalez-Carmona, Arne Kandulski, Daniel Roessler, Najib Ben Khaled, Stefan Enssle, Marino Venerito, Thorben W Fründt, Michael Schultheiß, Angela Djanani, (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11537570.txt.
Description
Tiago de Castro and a large team compare two first-line treatments for liver cancer in a 2024 study. One arm pairs atezolizumab with bevacizumab, an immune-based combo. The other uses lenvatinib, a targeted oral drug.
The cohort is a real-world European group, not a trial sample. Recent reports found surprisingly long survival on lenvatinib. The team compared effectiveness and outcomes across centers. Immune combos are the current standard of care. Head-to-head real-world data remain valuable for daily choices. Readers learn how the two options stack up outside the tidy world of trials.
Catalog record
| CREATOR | Tiago de Castro, Sabrina Welland, Leonie Jochheim, Cathrine Leyh, Kateryna Shmanko, Fabian Finkelmeier, Petia Jeliazkova, Andre Jefremow, Maria A Gonzalez-Carmona, Arne Kandulski, Daniel Roessler, Najib Ben Khaled, Stefan Enssle, Marino Venerito, Thorben W Fründt, Michael Schultheiß, Angela Djanani, |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |